Healthy and allergic twins exhibit distinct faecal microbial profiles, adding weight to idea that the microbiome may play a protective role in food allergies, according to a new study conducted by the University of Chicago and Stanford University,.
Swiss biotech company Evolva is launching a natural sugar blocker for food and drink applications. L-arabinose is also a reducing sugar, the company’s head of investor and corporate relations tells FoodNavigator.
Lonza is to sell off two European sites to NextPharma in a deal that gives the contract development and manufacturing firm facilities to work with lipid oral dosage forms for the nutrition and pharma markets.
British pharma company GlaxoSmithKline (GSK) are to pair up with Eligo Bioscience in a deal potentially worth €185m ($224m) that sees the firms target the microbiome to reduce the risk of developing acne.
FrieslandCampina Ingredients has identified the pursuit of health and wellbeing, personalised nutrition, convenience and sustainable authenticity as the four key trends that will shape the performance and active nutrition space in 2021.
The seismic events of 2020 have shaped consumer behaviours and expectations. The COVID-19 pandemic has reached every part of our lives – and the flavours we crave are no exception. Here’s our round-up of the flavour trends we can expect to tickle out...
Researchers in Australia say they have been able to significantly increase the short-term bioavailability of cannabidiol (CBD) in the blood and brain thanks to a new encapsulation technique, and the combined delivery with a ‘absorption enhancer’ - Deoxycholic...
Regular exercise may increase the abundance of bacteria associated with anti-inflammation and reduce the abundance of bacteria associated with pro-inflammation in physically inactive elderly women, says a new study from China.